Kaitlin Kellar, APRN
Women's Health · Covington, LANPI 1700660255
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Astellas Pharma US Inc at 33.6% of the total. Reporting peaked in 2024 at $415 and has fallen 64.9% since, to $146 in 2025.
Across 25 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$194
- Sumitomo Pharma America, Inc.$100
- Millicent US Inc$96
- Bayer$88
- Mayne Pharma Commercial LLC$45
- Coopersurgical, Inc.$20
- plus $33 from 2 others
What the payments were for
- Food & beverage$577100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $194 |
| Sumitomo Pharma America, Inc. | 6 | $100 |
| Millicent US Inc | 6 | $96 |
| Bayer | 1 | $88 |
| Mayne Pharma Commercial LLC | 2 | $45 |
| Coopersurgical, Inc. | 1 | $20 |
| Organon | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$103
How this compares
$577 in reported general payments places this provider in the 55th percentile of 128 women's health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 71 | $3,433 |
| Metronidazole | 12 | $280 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $246 |
| Fluconazole | 19 | $87 |
| Spironolactone | 13 | $53 |
Paid to pharmacies, not to this prescriber.
Other women's health in Covington
- Crystal AlackCovington$2K
- Jessica St GermainCovington$1K
- Julie PonderCovington$609
- Amanda HayesShreveport$51K
- Nancy WellsBossier City$47K
- Ann JoplingMonroe$16K
- Kendra Joseph-RodgersNew Orleans$10K
- Aundria CannonLafayette$5K
- Jordan ForsthoffLafayette$5K
- Jennifer MillerMonroe$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.